Dr. Luis R. Saraiva completed a Licenciatura (B.Sc.+M.Sc.) in Biology at the University of Evora (Portugal). After, he became a Fellow of the International Graduate School in Genetics and Functional Genomics of the University of Cologne in Germany, where he received his Ph.D. in Genetics (summa cum laude). After a brief period as a visiting scientist at Harvard Medical School in Boston, he worked as a postdoctoral scholar in the lab of Linda Buck (Nobel Laureate in Physiology and Medicine 2004) at the Fred Hutchinson Cancer Research Center in Seattle. As he became an EBI–Sanger Postdoctoral (ESPOD) Fellow, he moved to Cambridge, where he continued his postdoctoral training at the EMBL-EBI and the Wellcome Sanger Institute. Since 2015, he has been leading the Human Disease Modeling Laboratory, and he is currently also serving as the A/Director of the Disease Modeling and Therapeutics Department at the Research Branch of Sidra Medicine. From 2016–2023, he served as an Adjunct Faculty Member at the Monell Chemical Senses Center in Philadelphia. Additionally, since 2018, he has held a Joint Faculty position at Hamad bin Khalifa University (Doha, Qatar).
Dr. Luis R. Saraiva completed a Licenciatura (B.Sc.+M.Sc.) in Biology at the University of Evora (Portugal). After, he became a Fellow of the International Graduate School in Genetics and Functional Genomics of the University of Cologne in Germany, where he received his Ph.D. in Genetics (summa cum laude). After a brief period as a visiting scientist at Harvard Medical School in Boston, he worked as a postdoctoral scholar in the lab of Linda Buck (Nobel Laureate in Physiology and Medicine 2004) at the Fred Hutchinson Cancer Research Center in Seattle. As he became an EBI–Sanger Postdoctoral (ESPOD) Fellow, he moved to Cambridge, where he continued his postdoctoral training at the EMBL-EBI and the Wellcome Sanger Institute. Since 2015, he has been leading the Human Disease Modeling Laboratory, and he is currently also serving as the A/Director of the Disease Modeling and Therapeutics Department at the Research Branch of Sidra Medicine. From 2016–2023, he served as an Adjunct Faculty Member at the Monell Chemical Senses Center in Philadelphia. Additionally, since 2018, he has held a Joint Faculty position at Hamad bin Khalifa University (Doha, Qatar).